Division of Pulmonary and Critical Care, Department of Medicine.
Department of Pathology.
Medicine (Baltimore). 2020 Dec 18;99(51):e22559. doi: 10.1097/MD.0000000000022559.
Lung cancer is a leading cause of cancer-related deaths. Smoking is major risk factor for initial and subsequent lung cancer especially in active smokers. Treatment of subsequent lung cancer depends on whether it is synchronous or metachronous. We report a rare case of triple metachronous lung cancer and review of literature of patients with triple metachronous cancers. This will be the second case reported of triple metachronous lung cancer.
A 60-year-old male, active smoker with diabetes mellitus, chronic obstructive pulmonary disease (COPD) and peripheral arterial disease presented with cough and hemoptysis. Initial computed tomography (CT) scan showed right upper lobe spiculated mass.
He underwent transthoracic needle biopsy for right upper lobe mass, showing primary lung adenocarcinoma (ADC)-Stage-IIIA. He continued to smoke and 9-years later had new left upper lobe spiculated nodule, which on surgical resection showed squamous cell carcinoma (SCC)-Stage-IA1. Despite counselling on smoking cessation, he was unable to quit. Six months later, he presented with shortness of breath and CT chest showing right hilar adenopathy in right upper and lower lobes. He underwent transbronchial biopsies of lesion which showed small cell lung carcinoma (SCLC).
His initial lung ADC-Stage-IIIA, was treated with chemotherapy, weekly thoracic radiation and additional chemotherapy cycles. Nine years later, his left upper lobe mass showing SCC-Stage-IA1 was deemed curative after apical resection and he was kept on surveillance. Six months later, after diagnosis of SCLC in right upper and lower lobe, patient was not a candidate for systemic chemotherapy due to poor performance status and opted for hospice care.
His initial lung ADC-Stage-IIIA showed complete radiological response with chemotherapy and radiation. Subsequent SCC-Stage-IA1 was deemed curative after resection. Due to his poor performance status, he was not a candidate for chemotherapy for SCLC and patient opted for hospice care.
Smoking is a major risk factor for developing lung cancer and with continued smoking, patients are at higher risk for developing subsequent primary lung cancers. We recommend, patients with lung cancer must quit smoking, and those who do not, should remain on long-term surveillance.
肺癌是癌症相关死亡的主要原因。吸烟是初始和随后肺癌的主要危险因素,尤其是在活跃吸烟者中。随后肺癌的治疗取决于它是同步性的还是异时性的。我们报告了一例罕见的三发性肺癌病例,并对三发性癌症患者的文献进行了回顾。这将是第二例报告的三发性肺癌病例。
一名 60 岁男性,活跃吸烟者,患有糖尿病、慢性阻塞性肺疾病(COPD)和外周动脉疾病,出现咳嗽和咯血。初始计算机断层扫描(CT)显示右上肺叶有刺状肿块。
他接受了右上肺叶肿块的经胸针吸活检,显示原发性肺腺癌(ADC)-III 期。他继续吸烟,9 年后出现新的左上肺叶有刺状结节,手术切除后显示鳞状细胞癌(SCC)-IA1 期。尽管进行了戒烟咨询,但他无法戒烟。6 个月后,他出现呼吸急促,胸部 CT 显示右上肺和下肺门的纵隔淋巴结肿大。他接受了病变的经支气管活检,显示小细胞肺癌(SCLC)。
他最初的 ADC-III 期肺癌接受了化疗、每周胸部放疗和额外的化疗周期。9 年后,他的左上肺叶 SCC-IA1 被认为在 apical 切除后可以治愈,并进行了随访。6 个月后,在诊断出右肺上、下叶的 SCLC 后,由于患者的身体状况不佳,不适合全身化疗,因此选择了临终关怀。
他最初的 ADC-III 期肺癌在化疗和放疗后显示完全放射学反应。随后的 SCC-IA1 被认为在切除后可以治愈。由于他的身体状况不佳,他不适合接受 SCLC 的化疗,患者选择了临终关怀。
吸烟是肺癌发生的主要危险因素,持续吸烟会使患者发生后续原发性肺癌的风险更高。我们建议,肺癌患者必须戒烟,而那些不戒烟的患者应保持长期随访。